An Open-label, Single Arm Study to Evaluate the Efficacy and Safety and Tolerability of Tocilizumab (TCZ) Subcutaneous in TCZ-naive Patients With Active Rheumatoid Arthritis
Phase of Trial: Phase III
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Acronyms TOSCARA; TOZURA
- Sponsors Roche
- 17 Jun 2017 Results of pooled analysis, presented at the 18th Annual Congress of the European League Against Rheumatism.
- 19 Aug 2016 Last checked against European Clinical Trials Database record.
- 01 Oct 2015 Status changed from active, no longer recruiting to completed as reported by the ClinicalTrials.gov.